Stereotactic ablative radiotherapy (SABR) for early stage, non -small cell lung cancer (NSCLC): two year clinical outcome data from the Oxford Cancer Centre (OCC)

Pascal L., O'Cathail S., Higgins G., Ajzensztejn D., Stuart R., Panakis N.

Type

Conference paper

Publication Date

2020-01-01T00:00:00+00:00

Volume

139

Pages

S33 - S33

Permalink Close